Positive Research News for AWS with Endocannabinoid Palmitoylethanolamide Supplement Here are the highlights of the excellent review paper. Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. Abstract Treatment over 10 weeks in children with autism. At trial endpoint (week 10), combination of PEA and risperidone had superior efficacy in …
Recent Comments